Dr. Mohammad Chelehmalzadeh, M.D

NPI: 1902098460
Total Payments
$569.60
2023 Payments
$131.93
Companies
8
Transactions
29
Medicare Patients
2,044
Medicare Billing
$295,357

Payment Breakdown by Category

Food & Beverage$569.60 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $569.60 29 100.0%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $180.85 11 $0 (2021)
AstraZeneca Pharmaceuticals LP $126.77 9 $0 (2022)
AbbVie Inc. $113.08 1 $0 (2023)
E.R. Squibb & Sons, L.L.C. $39.92 2 $0 (2021)
Gilead Sciences, Inc. $37.64 2 $0 (2023)
CSL Behring $35.32 2 $0 (2022)
Allergan Inc. $21.48 1 $0 (2017)
Grifols USA, LLC $14.54 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $131.93 2 AbbVie Inc. ($113.08)
2022 $67.02 4 AstraZeneca Pharmaceuticals LP ($31.90)
2021 $159.14 8 PFIZER INC. ($83.81)
2020 $25.89 2 AstraZeneca Pharmaceuticals LP ($25.89)
2019 $44.63 3 PFIZER INC. ($44.63)
2018 $66.79 5 AstraZeneca Pharmaceuticals LP ($38.09)
2017 $74.20 5 PFIZER INC. ($23.71)

All Payment Transactions

29 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/10/2023 AbbVie Inc. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $113.08 General
Category: NEUROSCIENCE
03/15/2023 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.85 General
05/11/2022 Grifols USA, LLC HyperRAB (Biological) Food and Beverage In-kind items and services $14.54 General
Category: Immunology
03/22/2022 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $20.58 General
Category: Trauma (Emergency, Injury, Surgery)
03/09/2022 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $14.81 General
Category: Cardiovascular and Metabolism
03/01/2022 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $17.09 General
Category: Cardiovascular and Metabolism
12/16/2021 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $24.33 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/03/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.79 General
11/04/2021 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $16.82 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/13/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $16.20 General
Category: Cardiovascular
07/15/2021 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $20.04 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
04/20/2021 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $16.62 General
Category: Cardiovascular and Metabolism
03/03/2021 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $22.62 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
02/18/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $23.72 General
Category: Cardiovascular
10/15/2020 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $12.91 General
Category: Cardiovascular and Metabolism
09/22/2020 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $12.98 General
Category: Cardiovascular and Metabolism
12/16/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $16.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/12/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $14.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/08/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $14.63 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/18/2018 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $14.07 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
12/07/2018 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $13.29 General
Category: Cardiovascular and Metabolism
08/02/2018 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $12.82 General
Category: Cardiovascular and Metabolism
05/29/2018 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $14.63 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
04/19/2018 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $11.98 General
Category: Cardiovascular and Metabolism
09/18/2017 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $11.30 General
Category: CARDIOVASCULAR;METABOLIC DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 443 472 $702,622 $60,354
2022 4 465 495 $731,314 $70,160
2021 4 588 619 $933,989 $86,610
2020 4 548 585 $877,227 $78,232
Total Patients
2,044
Total Services
2,171
Medicare Billing
$295,357
Procedure Codes
15

All Medicare Procedures & Services

15 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 290 310 $527,298 $45,370 8.6%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 129 138 $157,108 $13,610 8.7%
99283 Emergency department visit with low level of medical decision making Facility 2023 24 24 $18,216 $1,375 7.5%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 331 360 $594,534 $58,051 9.8%
99284 Emergency department visit for problem of high severity Facility 2022 59 60 $66,150 $6,256 9.5%
99283 Emergency department visit for problem of moderate severity Facility 2022 64 64 $47,409 $3,668 7.7%
99291 Critical care, first 30-74 minutes Facility 2022 11 11 $23,221 $2,184 9.4%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 442 472 $778,328 $72,688 9.3%
99284 Emergency department visit, problem of high severity Facility 2021 71 72 $79,416 $7,529 9.5%
99283 Emergency department visit, moderately severe problem Facility 2021 60 60 $44,580 $3,755 8.4%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 15 15 $31,665 $2,638 8.3%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 403 430 $709,070 $63,878 9.0%
99284 Emergency department visit, problem of high severity Facility 2020 69 75 $82,725 $7,417 9.0%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 18 19 $40,109 $3,615 9.0%
99283 Emergency department visit, moderately severe problem Facility 2020 58 61 $45,323 $3,322 7.3%

About Dr. Mohammad Chelehmalzadeh, M.D

Dr. Mohammad Chelehmalzadeh, M.D is a Family Medicine healthcare provider based in Crosby, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902098460.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Chelehmalzadeh, M.D has received a total of $569.60 in payments from pharmaceutical and medical device companies, with $131.93 received in 2023. These payments were reported across 29 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($569.60).

As a Medicare-enrolled provider, Chelehmalzadeh has provided services to 2,044 Medicare beneficiaries, totaling 2,171 services with total Medicare billing of $295,357. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Emergency Medical Services
  • Location Crosby, MN
  • Active Since 08/17/2007
  • Last Updated 01/27/2016
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1902098460

Products in Payments

  • ELIQUIS (Drug) $192.07
  • BRILINTA (Drug) $126.77
  • QULIPTA (Drug) $113.08
  • Kcentra (Biological) $35.32
  • CHANTIX (Drug) $28.70
  • TEFLARO (Drug) $21.48
  • HyperRAB (Biological) $14.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Crosby